Latest Psoriasis Stories

The U.S. Patent and Trademark Office has granted Noreen Mulvanerty, a Board Certified Family Nurse Practitioner and Herbalist, a patent for her revolutionary healing herbal first aid spray, Omyst®. The one ounce spray expedites healing of a wide array of skin conditions, including burns, scratches, scrapes, rashes, insect bites, bed bug bites, eczema, poison ivy, stings as well as sutures, psoriasis and shingles Rockaway Beach, NY (PRWEB) May 11, 2012 The U.S. Patent and Trademark...

NEW YORK, May 7, 2012 /PRNewswire/ -- Provectus Pharmaceuticals, Inc. (OTCBB: PVCT, http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, today announced that its May 3rd RetailInvestorConferences.com presentation is now available for on-demand viewing. LINK: www.retailinvestorconferences.com > red "register/ watch event now" button Provectus Pharmaceuticals, Inc's presentation will be available for 90 days. Investors may download...

LUXEMBOURG, May 3, 2012 /PRNewswire/ -- Creabilis SA, a European biotechnology company specialising in the development of treatments for dermatology, inflammation and pain, announces today that Dr Simon Russell has been appointed as Chief Business Officer. Dr Russell joins Creabilis from Novartis Pharma AG where he held a number global strategic marketing roles and most recently Head of Global Marketing for ILARIS (canakinumab). He was previously Head of Strategic...

ST PAUL, Minn., May 2, 2012 /PRNewswire-iReach/ -- The most common models for evaluating skin-related inflammation are time consuming and expensive. While they provide valuable data, they don't allow for rapid and cost effective evaluation of therapeutics earlier in the preclinical pipeline. In response to this need for more convenient and cost effective models, researchers (Van der Fits et al, 2009) developed a model using Imiquimod (IMQ) to induce psoriasis-like inflammation....

NEW YORK, April 30, 2012 /PRNewswire/ -- Provectus Pharmaceuticals, Inc. (OTCBB: PVCT, http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, today announced that Craig Dees, Ph.D., CEO, will be presenting at RetailInvestorConferences.com. DATE: May 3, 2012TIME: 1:00 PM EDTLINK: www.retailinvestorconferences.com > red "register / watch event now" button This will be a live, interactive online event where investors are invited to ask the...

BRONXVILLE, N.Y., April 24, 2012 /PRNewswire/ -- Your skin is the largest organ of your body. It protects you from harmful bacteria and viruses that can cause infections. It also helps your body sense the outside world and regulate your body temperature. (Photo: http://photos.prnewswire.com/prnh/20120424/NY92780) Therefore, it should come as no surprise that billions of dollars are spent each year on skin care products, and billions more are spent on medical costs to treat damaged...

Tokyo, Apr 23, 2012 - (JCN Newswire) - Abbott Japan Co., Ltd. and Eisai Co., Ltd. announced today that they have received notification from Japan's Ministry of Health, Labour and Welfare (MHLW) that the condition for approval of Humira(R) pre-filled syringe 40 mg/0.8 mL for subcutaneous injection (adalimumab [genetical recombination]), a fully human anti-TNF-alpha monoclonal antibody, has been lifted in terms of a drug use results survey (all-case surveillance)...

(Ivanhoe Newswire) -- When the impact of skin diseases on the lives of those it affects usually is considered a "cosmetic problem."  The most common autoimmune disease known as alopecia areata is an example of the lack of attention on skin diseases.  The pathobiology of the disease and available therapies are disappointing, according to a recent study. In the New England Journal of Medicine, scientists offer a review of the clinical presentation, pathogenesis, and management of alopecia...

Scientists led by Washington University School of Medicine in St. Louis have identified the first gene directly linked to the most common form of psoriasis, a chronic skin condition. The research shows that rare mutations in the CARD14 gene, when activated by an environmental trigger, can lead to plaque psoriasis. This type of psoriasis accounts for 80 percent of all cases and is characterized by dry, raised, red patches covered with silvery scales that can be itchy and painful. The new...

Psoriasal found to be an effective new treatment for psoriasis and chronic wound care. Portland, Oregon (PRWEB) April 07, 2012 TCM Holdings Group, Inc. http://www.tcmholdingsinc.com announces strategic marketing relationship with Psoriasal. The companies will work together to develop marketing channels and licensing agreements for skin care products. A revolutionary new patented skin care product, created with all natural ingredients, has been introduced by Bioscience expert, Dr....